|
LXEO Lexeo Therapeutics Inc 1907108 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-25,867,000.00 |
| Balance Sheet |
|
Current Assets
|
$217,908,000.00 |
|
Assets
|
$254,898,000.00 |
|
Current Liabilities
|
$15,692,000.00 |
|
Liabilities
|
$19,837,000.00 |
|
Equity
|
$235,061,000.00 |
|
Shares Out
|
78622604.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-38,741,000.00 |
|
Investing Cash Flow
|
$41,724,000.00 |
| Market Analysis |
Market Cap
|
$397,830,376.24 |
|
Price
|
$5.06 |
|
BVPS
|
2.99 |
|
PB
|
1.69 |
|
EPS
|
-0.30 |
|
FCF
|
$-38,783,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:41 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:32 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-0.27 |
|
|
2026-05-11 |
-0.25 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.60 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.33 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LXEO documents filed with the SEC.
LXEO Filings
Clear
